Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “SGLT2 Inhibitors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT04035031
What this trial is testing

Effects of Dapagliflozin on Hormonal Glucose Homeostasis in Type 1 Diabetes

Who this might be right for
Diabetes Mellitus, Type 1
Insel Gruppe AG, University Hospital Bern 13
Testing effectiveness (Phase 2)Study completedNCT03951805
What this trial is testing

A Research Study to Compare Two Types of Insulin: Insulin 287 and Insulin Glargine in People With Type 2 Diabetes Who Have Not Used Insulin Before

Who this might be right for
Diabetes Mellitus, Type 2
Novo Nordisk A/S 205
Post-approval studies (Phase 4)Looking for participantsNCT04662723
What this trial is testing

Multicentre Clinical Study to Evaluate the Effect of Personalized Therapy on Patients With Immunoglobulin A Nephropathy.

Who this might be right for
GlomerulonephritisImmunoglobulin A Nephropathy
Fondazione Schena 878
Post-approval studies (Phase 4)Not Yet RecruitingNCT07527390
What this trial is testing

CANagliflozin In DIALysis Patients

Who this might be right for
DialysisChronic Kidney Disease (Stages 4 and 5)
University Medical Center Groningen 10
Post-approval studies (Phase 4)Active Not RecruitingNCT05590143
What this trial is testing

ProMoting Effective Renoprotection in Cardiac sURgery Patients by Inhibition of SGLT-2

Who this might be right for
Acute Kidney InjuryCardiac SurgerySodium-Glucose Transporter 2 Inhibitor
Amsterdam UMC 784
Testing effectiveness (Phase 2)Study completedNCT04907214
What this trial is testing

SGLT2 Inhibitor Effects on Inflammation and Heart Disease in Obesity Pilot

Who this might be right for
ObesityPre-diabetes
Vanderbilt University Medical Center 29
Testing effectiveness (Phase 2)WithdrawnNCT05058859
What this trial is testing

Long Term Clinical Efficacy of Sodium-glucose Cotransporter-2 (SGLT-2) Inhibitor in Cystinurics

Who this might be right for
Cystinuria
University of California, San Francisco
Not applicableUnknownNCT06344247
What this trial is testing

Comparison of the Efficacy and Safety of SGLT2i and GLP-1 Receptor Agonists in Obese Patients With Kidney Disease

Who this might be right for
ObesityChronic Kidney Diseases
RenJi Hospital 48
Testing effectiveness (Phase 2)Looking for participantsNCT06155604
What this trial is testing

SGLT2 Inhibitor in Lupus Nephritis Patients With Chronic Kidney Disease

Who this might be right for
Lupus NephritisChronic Kidney Diseases
The University of Hong Kong 150
Post-approval studies (Phase 4)Study completedNCT05621551
What this trial is testing

Dapagliflozin Therapy In Cardiac Surgery

Who this might be right for
Diabetes Mellitus, Type 2Cardiac Surgery
China National Center for Cardiovascular Diseases 178
Not applicableStudy completedNCT06903754
What this trial is testing

ISGLT2 in Patients Without DM With Acute MI

Who this might be right for
Acute Coronary SyndromesHeart Failure
Mohammed VI University Hospital 450
Post-approval studies (Phase 4)Ended earlyNCT02462421
What this trial is testing

Pharmacogenetics of SGLT2 Inhibitors

Who this might be right for
Diabetes MellitusGoutHyperuricemia
University of Maryland, Baltimore 30
Testing effectiveness (Phase 2)Looking for participantsNCT07174687
What this trial is testing

SGLT2 Inhibitors in Geographic Atrophy

Who this might be right for
Retinal DegenerationRetinal DiseasesEye Diseases+2 more
Washington University School of Medicine 70
Large-scale testing (Phase 3)UnknownNCT05776043
What this trial is testing

Empagliflozin and Dapagliflozin in Patients Hospitalized for Acute Decompensated Heart Failure

Who this might be right for
Acute Decompensated Heart Failure
Medical University of Warsaw 1,364
Not applicableActive Not RecruitingNCT07602348
What this trial is testing

Assessment of Retinal-Angio Findings In Patients With Diabetes Type II Treated With Novel Antidiabetic Therapies

Who this might be right for
Diabetic RetinopathyGLP-1SGLT 2 Inhibitors+3 more
University of Athens 40
Not applicableStudy completedNCT06951737
What this trial is testing

Evaluation Of The Effect Of SGLT-2 Inhibitors On Atrial Fibrillation Recurrence In Diabetic Patients

Who this might be right for
Diabetes MellitusAtrial Fibrillation (AF)
Bursa Postgraduate Hospital 120
Large-scale testing (Phase 3)Looking for participantsNCT07038356
What this trial is testing

Effects of Continued Administration of Empagliflozin in Patients With Heart Failure on Active SGLT2 Inhibitor Treatment Admitted for Acute Decompensated Heart Failure

Who this might be right for
Acute Decompensated Heart Failure (ADHF)
Christian Schulze 536
Large-scale testing (Phase 3)Looking for participantsNCT07056699
What this trial is testing

SGLT2i, Pioglitazone, and Ketone Production in T1D

Who this might be right for
Type1diabetes
The University of Texas Health Science Center at San Antonio 24
Post-approval studies (Phase 4)Looking for participantsNCT07614230
What this trial is testing

SGLT2 Inhibitors on Coronary Atherosclerosis Progression Via Perivascular Adipose Tissue in Diabetes

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)Coronary Artery DiseaseAtherosclerosis
Junjie Yang 144
Early research (Phase 1)Active Not RecruitingNCT02891954
What this trial is testing

Genetics of Response to Canagliflozin

Who this might be right for
Diabetes Mellitus, Type 2
University of Maryland, Baltimore 700
Next Page